{"id":"W2581612511","doi":"10.1007/s41669-017-0011-x","title":"Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Astellas Pharma Global Development; Astellas Pharma Europe; Astellas Pharma; Canadian Urological Association; Duchesnay; Pfizer","keywords":"Mirabegron; Tolterodine; Overactive bladder; Oxybutynin; Solifenacin; Medicine; Urology; Cohort; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003493066,0.0007244974,0.001014336,0.0007898114,0.000277699,0.002109411,0.0007759535,0.001479639,0.003225547],"category_scores_gemma":[0.0145793,0.0005647347,0.002242274,0.0008604451,0.0006053434,0.0015105,0.001213076,0.00112625,0.0001833335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01008365,"about_ca_system_score_gemma":0.002332295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05862328,"about_ca_topic_score_gemma":0.02874808,"domain_scores_codex":[0.9963706,0.002558764,0.0001534096,0.0002394092,0.0002734045,0.0004043845],"domain_scores_gemma":[0.9943124,0.003787337,0.001046538,0.00009844232,0.0004115303,0.00034378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.008148471,0.0002997532,0.07993913,0.001820294,0.002459303,0.001674702,0.0002037374,0.8699391,0.0007301505,0.008522703,0.004127308,0.02213529],"study_design_scores_gemma":[0.003407884,0.007241469,0.1375268,0.002359584,0.003529604,0.002417868,0.001313835,0.8211525,0.001424516,0.009843788,0.009500364,0.0002818944],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9611485,0.01525127,0.004243919,0.004539654,0.0001965779,0.0002810762,0.005128051,0.0000396507,0.009171268],"genre_scores_gemma":[0.997543,0.001030375,0.0003333242,0.000193401,0.00001032306,0.00003238832,0.0004059115,0.000004267491,0.0004471312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05862328,"threshold_uncertainty_score":0.1165641,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1589304446283486,"score_gpt":0.5192326041491452,"score_spread":0.3603021595207966,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}